Pediatrix Medical Group, Inc.

NYSE MD

Pediatrix Medical Group, Inc. Return on Capital Employed (ROCE) for the Trailing 12 Months (TTM) ending September 30, 2024: -12.61%

Pediatrix Medical Group, Inc. Return on Capital Employed (ROCE) is -12.61% for the Trailing 12 Months (TTM) ending September 30, 2024, a -245.15% change year over year. Return on capital employed assesses profitability against invested capital; higher ROCE signals efficient capital use.
  • Pediatrix Medical Group, Inc. Return on Capital Employed (ROCE) for the Trailing 12 Months (TTM) ending September 30, 2023 was 8.69%, a 16.08% change year over year.
  • Pediatrix Medical Group, Inc. Return on Capital Employed (ROCE) for the Trailing 12 Months (TTM) ending September 30, 2022 was 7.49%, a -7.02% change year over year.
  • Pediatrix Medical Group, Inc. Return on Capital Employed (ROCE) for the Trailing 12 Months (TTM) ending September 30, 2021 was 8.05%, a 40.63% change year over year.
  • Pediatrix Medical Group, Inc. Return on Capital Employed (ROCE) for the Trailing 12 Months (TTM) ending September 30, 2020 was 5.73%, a 1.07% change year over year.
Key data
Date Return on Capital Employed (ROCE) Interest Coverage Ratio Debt to Equity Ratio Return on Common Equity
Market news
Loading...
NYSE: MD

Pediatrix Medical Group, Inc.

CEO Dr. James D. Swift M.D.
IPO Date Sept. 20, 1995
Location United States
Headquarters 1301 Concord Terrace
Employees 5,450
Sector Consumer Staples
Industries
Description

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, ultrasonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. As of February 17, 2022, it operated a network of approximately 2,700 physicians. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.

Similar companies

UHS

Universal Health Services, Inc.

USD 184.16

-0.85%

PBH

Prestige Consumer Healthcare Inc.

USD 75.78

1.54%

SEM

Select Medical Holdings Corporation

USD 18.92

0.64%

USPH

U.S. Physical Therapy, Inc.

USD 88.70

-0.64%

ACHC

Acadia Healthcare Company, Inc.

USD 44.37

-2.29%

StockViz Staff

January 15, 2025

Any question? Send us an email